The UK government has revealed a comprehensive life sciences strategy led by Professor Sir John Bell, aiming to strengthen the sector after Brexit through increased funding and policy reforms.
Recent data reveals a concerning trend as UK drops from 2nd to 10th place in European rankings for orphan medicine availability, signaling declining access to rare disease treatments.
The UK's NHS has seen a dramatic shift in healthcare delivery, with 71% of routine GP consultations now conducted remotely, compared to just 25% before the COVID-19 pandemic.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.